NBIX logo

Neurocrine Biosciences (NBIX) Total expenses

Annual total expenses:

$1.77B+$280.00M(+18.76%)
December 31, 2024

Summary

  • As of today (May 29, 2025), NBIX annual total expenses is $1.77 billion, with the most recent change of +$280.00 million (+18.76%) on December 31, 2024.
  • During the last 3 years, NBIX annual total expenses has risen by +$846.60 million (+91.46%).
  • NBIX annual total expenses is now at all-time high.

Performance

NBIX Total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Quarterly total expenses:

$548.90M+$66.20M(+13.71%)
March 31, 2025

Summary

  • As of today (May 29, 2025), NBIX quarterly total expenses is $548.90 million, with the most recent change of +$66.20 million (+13.71%) on March 31, 2025.
  • Over the past year, NBIX quarterly total expenses has increased by +$138.90 million (+33.88%).
  • NBIX quarterly total expenses is now at all-time high.

Performance

NBIX Quarterly total expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXincome statement metrics

Total expenses Formula

Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses

NBIX Total expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+18.8%+33.9%
3 y3 years+91.5%+78.5%
5 y5 years+215.6%+208.0%

NBIX Total expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+91.5%at high+82.9%
5 y5-yearat high+215.6%at high+211.7%
alltimeall timeat high>+9999.0%at high>+9999.0%

NBIX Total expenses History

DateAnnualQuarterly
Mar 2025
-
$548.90M(+13.7%)
Dec 2024
$1.77B(+18.8%)
$482.70M(+10.4%)
Sep 2024
-
$437.30M(-1.1%)
Jun 2024
-
$442.30M(+7.9%)
Mar 2024
-
$410.00M(+12.4%)
Dec 2023
$1.49B(+20.4%)
$364.90M(+2.0%)
Sep 2023
-
$357.60M(-5.7%)
Jun 2023
-
$379.10M(-3.0%)
Mar 2023
-
$390.70M(+26.6%)
Dec 2022
$1.24B(+33.9%)
$308.60M(+2.8%)
Sep 2022
-
$300.10M(-7.2%)
Jun 2022
-
$323.50M(+5.2%)
Mar 2022
-
$307.50M(+24.0%)
Dec 2021
$925.70M(+28.9%)
$248.00M(-1.4%)
Sep 2021
-
$251.50M(+13.7%)
Jun 2021
-
$221.10M(+7.8%)
Mar 2021
-
$205.10M(+16.5%)
Dec 2020
$718.40M(+27.9%)
$176.10M(-4.4%)
Sep 2020
-
$184.30M(+2.5%)
Jun 2020
-
$179.80M(+0.9%)
Mar 2020
-
$178.20M(+12.0%)
Dec 2019
$561.50M(+37.1%)
$159.10M(+20.5%)
Sep 2019
-
$132.00M(-8.4%)
Jun 2019
-
$144.10M(+14.1%)
Mar 2019
-
$126.30M(+20.4%)
Dec 2018
$409.60M(+55.7%)
$104.88M(+7.6%)
Sep 2018
-
$97.43M(-1.3%)
Jun 2018
-
$98.76M(-9.0%)
Mar 2018
-
$108.53M(+106.0%)
Dec 2017
$262.99M(+62.0%)
$52.68M(-21.1%)
Sep 2017
-
$66.77M(+5.0%)
Jun 2017
-
$63.60M(-20.4%)
Mar 2017
-
$79.93M(+72.8%)
Dec 2016
$162.37M(+42.5%)
$46.25M(+20.3%)
Sep 2016
-
$38.44M(-8.1%)
Jun 2016
-
$41.83M(+16.7%)
Mar 2016
-
$35.86M(+16.6%)
Dec 2015
$113.97M(+76.9%)
$30.75M(-14.2%)
Sep 2015
-
$35.84M(+41.6%)
Jun 2015
-
$25.32M(+14.8%)
Mar 2015
-
$22.06M(+7.8%)
Dec 2014
$64.41M(+22.5%)
$20.47M(+21.4%)
Sep 2014
-
$16.86M(+17.4%)
Jun 2014
-
$14.36M(+12.9%)
Mar 2014
-
$12.72M(+3.8%)
Dec 2013
$52.60M(+1.8%)
$12.26M(-3.7%)
Sep 2013
-
$12.73M(-8.4%)
Jun 2013
-
$13.90M(+1.4%)
Mar 2013
-
$13.71M(+2.5%)
Dec 2012
$51.69M(+18.9%)
$13.37M(+0.3%)
Sep 2012
-
$13.32M(+11.5%)
Jun 2012
-
$11.95M(-8.5%)
Mar 2012
-
$13.06M(+22.5%)
Dec 2011
$43.49M(-7.9%)
$10.66M(-4.7%)
Sep 2011
-
$11.19M(+1.2%)
Jun 2011
-
$11.06M(+4.6%)
Mar 2011
-
$10.57M(-23.3%)
Dec 2010
$47.22M
$13.79M(+15.1%)
DateAnnualQuarterly
Sep 2010
-
$11.98M(+13.8%)
Jun 2010
-
$10.53M(-3.6%)
Mar 2010
-
$10.92M(-16.1%)
Dec 2009
$54.07M(-39.4%)
$13.02M(+25.6%)
Sep 2009
-
$10.37M(-33.7%)
Jun 2009
-
$15.63M(+3.9%)
Mar 2009
-
$15.04M(-48.8%)
Dec 2008
$89.22M(-58.2%)
$29.39M(+78.5%)
Sep 2008
-
$16.46M(-21.0%)
Jun 2008
-
$20.85M(-7.4%)
Mar 2008
-
$22.51M(-82.6%)
Dec 2007
$213.47M(+39.9%)
$129.13M(+339.7%)
Sep 2007
-
$29.37M(+6.4%)
Jun 2007
-
$27.60M(+0.8%)
Mar 2007
-
$27.38M(+6.5%)
Dec 2006
$152.55M(+2.4%)
$25.70M(-37.7%)
Sep 2006
-
$41.27M(+7.2%)
Jun 2006
-
$38.51M(-18.2%)
Mar 2006
-
$47.07M(+21.6%)
Dec 2005
$148.96M(+8.3%)
$38.70M(-2.3%)
Sep 2005
-
$39.62M(+0.5%)
Jun 2005
-
$39.42M(+26.3%)
Mar 2005
-
$31.21M(-21.3%)
Dec 2004
$137.51M(-30.5%)
$39.67M(+5.1%)
Sep 2004
-
$37.73M(+32.7%)
Jun 2004
-
$28.44M(-10.2%)
Mar 2004
-
$31.67M(-28.8%)
Dec 2003
$197.87M(+62.6%)
$44.51M(+3.9%)
Sep 2003
-
$42.83M(-25.5%)
Jun 2003
-
$57.46M(+8.3%)
Mar 2003
-
$53.07M(+17.5%)
Dec 2002
$121.66M(+42.9%)
$45.15M(+64.3%)
Sep 2002
-
$27.48M(+4.7%)
Jun 2002
-
$26.25M(+15.2%)
Mar 2002
-
$22.78M(-19.3%)
Dec 2001
$85.12M(+69.6%)
$28.24M(+38.4%)
Sep 2001
-
$20.40M(+7.8%)
Jun 2001
-
$18.92M(+7.7%)
Mar 2001
-
$17.57M(+18.3%)
Dec 2000
$50.19M(+36.8%)
$14.86M(-1.0%)
Sep 2000
-
$15.01M(+45.4%)
Jun 2000
-
$10.32M(+3.2%)
Mar 2000
-
$10.00M(+8.7%)
Dec 1999
$36.70M(+29.2%)
$9.20M(-9.8%)
Sep 1999
-
$10.20M(+12.1%)
Jun 1999
-
$9.10M(+12.3%)
Mar 1999
-
$8.10M(-1.2%)
Dec 1998
$28.40M(+10.9%)
$8.20M(0.0%)
Sep 1998
-
$8.20M(+43.9%)
Jun 1998
-
$5.70M(-12.3%)
Mar 1998
-
$6.50M(-13.3%)
Dec 1997
$25.60M(+57.1%)
$7.50M(+13.6%)
Sep 1997
-
$6.60M(+15.8%)
Jun 1997
-
$5.70M(0.0%)
Mar 1997
-
$5.70M(-5.0%)
Dec 1996
$16.30M
$6.00M(+62.2%)
Sep 1996
-
$3.70M(-11.9%)
Jun 1996
-
$4.20M(+75.0%)
Mar 1996
-
$2.40M

FAQ

  • What is Neurocrine Biosciences annual total expenses?
  • What is the all time high annual total expenses for Neurocrine Biosciences?
  • What is Neurocrine Biosciences annual total expenses year-on-year change?
  • What is Neurocrine Biosciences quarterly total expenses?
  • What is the all time high quarterly total expenses for Neurocrine Biosciences?
  • What is Neurocrine Biosciences quarterly total expenses year-on-year change?

What is Neurocrine Biosciences annual total expenses?

The current annual total expenses of NBIX is $1.77B

What is the all time high annual total expenses for Neurocrine Biosciences?

Neurocrine Biosciences all-time high annual total expenses is $1.77B

What is Neurocrine Biosciences annual total expenses year-on-year change?

Over the past year, NBIX annual total expenses has changed by +$280.00M (+18.76%)

What is Neurocrine Biosciences quarterly total expenses?

The current quarterly total expenses of NBIX is $548.90M

What is the all time high quarterly total expenses for Neurocrine Biosciences?

Neurocrine Biosciences all-time high quarterly total expenses is $548.90M

What is Neurocrine Biosciences quarterly total expenses year-on-year change?

Over the past year, NBIX quarterly total expenses has changed by +$138.90M (+33.88%)
On this page